J. Luna
Impact in
- Immunology and Allergy top 10%
- Cell Adhesion Molecules Research
- Ophthalmology top 10%
- Retinal Diseases and Treatments
Papers in
-
- Lung Cancer Diagnosis and Treatment 9
- Lung Cancer Treatments and Mutations 8
- Brain Metastases and Treatment 2
- Oncology 11
- Lung Cancer Research Studies 6
- Cancer Immunotherapy and Biomarkers 3
- COVID-19 and healthcare impacts 2
- Co-authors
- Takao Tobe (1 shared paper)Peter A. Campochiaro (1 shared paper)Shaker A. Mousa (1 shared paper)Thomas M. Reilly (1 shared paper)I. Prieto (6 shared papers)Felipe Couñago (11 shared papers)Enrique Amaya (2 shared papers)Aurora Rodríguez (5 shared papers)
- Journals
- World Journal of Clinical Oncology (5 papers)International Journal of Radiation Oncology*Biology*Physics (3 papers)Cancers (2 papers)Clinical & Translational Oncology (2 papers)Radiotherapy and Oncology (2 papers)
- Partner nations
- SpainArgentinaUnited Kingdom
In The Last Decade
J. Luna
22 papers receiving 316 citations
Peers
Comparison fields: 5 of 60
- Immunology and Allergy 44
- Ophthalmology 60
- Oncology 101
- Pulmonary and Respiratory Medicine 121
- Cancer Research 50
Countries citing papers authored by J. Luna
This map shows the geographic impact of J. Luna's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Luna with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Luna more than expected).
Fields of papers citing papers by J. Luna
This network shows the impact of papers produced by J. Luna. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Luna. The network helps show where J. Luna may publish in the future.
Co-authors
The 25 scholars most cited alongside J. Luna, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Antagonists of integrin alpha v beta 3 inhibit retinal neovascularization in a murine model. | 1996 | 98 |
| 2 | 2016 | 61 | |
| 3 | 2019 | 37 | |
| 4 | 2020 | 17 | |
| 5 | 2021 | 16 | |
| 6 | 2021 | 16 | |
| 7 | 2016 | 14 | |
| 8 | 2018 | 12 | |
| 9 | 2018 | 10 | |
| 10 | 2020 | 9 | |
| 11 | 2021 | 9 | |
| 12 | 2022 | 5 | |
| 13 | 2021 | 5 | |
| 14 | 2015 | 3 | |
| 15 | 2023 | 2 | |
| 16 | 2021 | 2 | |
| 17 | 2012 | 1 | |
| 18 | 2023 | 1 | |
| 19 | 2021 | 1 | |
| 20 | 2015 | 1 |
About J. Luna
J. Luna is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Radiology, Nuclear Medicine and Imaging, Surgery and Radiation, having authored 23 papers that have together received 322 indexed citations. Recurring topics across this work include Lung Cancer Diagnosis and Treatment (9 papers), Lung Cancer Treatments and Mutations (8 papers), Lung Cancer Research Studies (6 papers), Cancer Immunotherapy and Biomarkers (3 papers), Endometrial and Cervical Cancer Treatments (2 papers), Brain Metastases and Treatment (2 papers), Advanced Radiotherapy Techniques (2 papers) and COVID-19 and healthcare impacts (2 papers). The work is most often cited by research in Immunology and Allergy (44 citations), Ophthalmology (60 citations), Oncology (101 citations), Pulmonary and Respiratory Medicine (121 citations) and Cancer Research (50 citations). J. Luna has collaborated with scholars based in Spain, Argentina and United Kingdom. Frequent co-authors include Takao Tobe, Peter A. Campochiaro, Shaker A. Mousa, Thomas M. Reilly, I. Prieto, Felipe Couñago, Enrique Amaya, Aurora Rodríguez, Núria Rodríguez and Xabier Mielgo-Rubio. Their work appears in journals such as World Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics, Cancers, Clinical & Translational Oncology and Radiotherapy and Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.